CLINICAL PRACTICE GUIDELINE FOR DIAGNOSTICS., TREATMENT AND PROGNOSIS OF MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS

1. Добронравов В.А., Дунаева Н.В. Поражение почек и хронический вирусный гепатит С. Нефрология 2008; 12 (4): 9-192.

2. Лора Ш., Фремю-Бачи В. Атипичный гемолитико- уремический синдром. Нефрология 2012; 16 (2): 16-48

3. Ферри С. Смешанная криоглобулинемия. Нефрология 2010; 14 (1): 11-28

4. Appel G.B. Membranoproliferative glomerulonephritis -mechanisms and treatment // Contrib Nephrol. 2013; 181: 163-174

5. D’Agati V.D., Bomback A.S. C3 glomerulopathy: what’s in a name? // Kidney Int. 2012; 82: 379-381

6. Bomback A.S., Appel G.B. Pathogenesis of the C3 glomerulopathies and reclassification of MPGN // Nat. Rev. Nephrol. 2012; 8: 634-642

7. Bomback A.S., Smith R.J., Barile G.R. et al. Eculisumab for dense deposit disease and C3 glomerulonephritis // Clin. J. Am. Soc. Nephrol. 2012; 7: 748- 756

8. KDIGO Clinical practice guideline for glomerulonephritis // Kidney Int. Suppl. 2012; 2(2): 198- 200

9. Fervensa F.C., Sethi S., Glassock R.J. Idiopathic membraneproliferative glomerulonephritis: does it exist? // Nephrol Dial Transpant. 2012; 27(12): 4288-42-94

10. Fregonese L., Stolk J. Hereditary alpha-1-antitrypsin deficiency and its clinical conseguence // Orphanet J. Rare Diseases. 2008; 3: 16

11. Hou J., Markowitz G.S., Bomback A.S. et al. Toward a working definition of C3 glomerulopathy by immunofluorescence // Kidney Int 2013; Sept 25 [Epub ahead of print]

12. Morales J.M., Kamar N., Rostaing L. Hepatitis C and renal disease: epidemiology, diagnosis, pathogenesis and therapy // Contrib Nephrol. Bazel Karger 2012; 176: 10-23

13. Pickering M.C., Cook H.H. Complement and glomerular disease: new insights // Curr Opin. Nephrol Hypertens. 2011; 20: 271-277

14. Pickering M.C., DAgati V.D., Nester C.M. et al. C3 glomerulopathy: consensus report // Kidney Int 2013, Oct 30 [Epub ahead of print]

15. Sethi S., Fervenza F.C. Memranoproliferative glomerulonephritis - a new look at an old entity // N. Engl. J. Med. 2012; 366: 1119- 1131

16. Servias A., Noël L.-H., Roumenina L.T. et al. Acguired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies // Kidney Int 2012; 82: 454-464

17. Smith R.J.H., Harris C.Z., Pickering M.C. Dense Deposit Disease // Mol. Immunol. 2011; 48: 1604- 1610

18. Sun Q., Huang X., Jiang S. et al. Picking transplant glomerulopathy out of the CAN: evidence from a clinicopathological evaluation // BMC Nephrology 2012; 13: 128